Faculty, Staff and Student Publications
Publication Date
7-4-2025
Journal
Scientific Reports
DOI
10.1038/s41598-025-09075-y
PMID
40615649
PMCID
PMC12227561
PubMedCentral® Posted Date
7-4-2025
PubMedCentral® Full Text Version
Post-print
Abstract
Traditional gene expression deconvolution methods assess a limited number of cell types, therefore do not capture the full complexity of the tumor microenvironment (TME). Here, we integrate nine deconvolution tools to assess 79 TME cell types in 10,592 tumors across 33 different cancer types, creating the most comprehensive analysis of the TME. In total, we found 41 patterns of immune infiltration and stroma profiles, identifying heterogeneous yet unique TME portraits for each cancer and several new findings. Our findings indicate that leukocytes play a major role in distinguishing various tumor types, and that a shared immune-rich TME cluster predicts better survival in bladder cancer for luminal and basal squamous subtypes, as well as in melanoma for RAS-hotspot subtypes. Our detailed deconvolution and mutational correlation analyses uncover 35 therapeutic target and candidate response biomarkers hypotheses (including CASP8 and RAS pathway genes).
Keywords
Tumor microenvironment, iScores, Integrated scores, Cell type estimation, Deconvolution, Pan-cancer analysis, Immune cells, Stroma, Survival, Tumor progression, Somatic mutations, Computational biology and bioinformatics, Cancer, Cancer microenvironment
Published Open-Access
yes
Recommended Citation
Bhinder, Bhavneet; Friedl, Verena; Sethuraman, Sunantha; et al., "Pan-Cancer Immune and Stromal Deconvolution Predicts Clinical Outcomes and Mutation Profiles" (2025). Faculty, Staff and Student Publications. 4637.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/4637
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Genetic Phenomena Commons, Medical Genetics Commons, Oncology Commons